Tonix2.jpg
Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014
March 03, 2014 09:35 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 3, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it recently held a...
Tonix2.jpg
Tonix Pharmaceuticals Spotlighted in Three Media Outlets in February
February 21, 2014 08:20 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, has been featured in TheStreet.com, Genetic...
Tonix2.jpg
Tonix Pharmaceuticals to Present at the BIO CEO Conference
February 04, 2014 08:40 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 16th Annual BIO CEO &...
Tonix2.jpg
Tonix Pharmaceuticals Announces Closing of $43.5 Million Public Offering of Common Stock
January 29, 2014 11:15 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares...
Tonix2.jpg
Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
January 24, 2014 08:20 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 24, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 2,898,550 shares of its common stock at...
Tonix2.jpg
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
January 23, 2014 16:02 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it intends to offer shares of...
Tonix2.jpg
Tonix Pharmaceuticals Announces the Enrollment of Completers From the BESTFIT Trial Into a 12-Month Open-Label Extension Study
December 10, 2013 08:40 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, announced today that it is enrolling subjects into...
Tonix2.jpg
Tonix Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
November 26, 2013 08:40 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 24th Annual Oppenheimer...
Tonix2.jpg
Tonix Pharmaceuticals to Present at the LD Micro Conference
November 21, 2013 09:05 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 6th Annual LD Micro...
Tonix2.jpg
Tonix Pharmaceuticals Reports Third Quarter 2013 Financial Results
November 13, 2013 16:05 ET | Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced its financial results for the quarter ended September 30, 2013. "The third quarter was...